本文へ移動
cccskills
無料GitHub で公開

endo-assess-cgm-data-diff-smbg

Assesses patient’s understanding of how CGM data (trends, rates of change) differ from discrete SMBG fingerstick values. Triggered when clinicians hear requests to explain lag and trend arrows on CGM or teach the difference between CGM glucose and fingerstick glucose.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.6 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Assess understanding of how CGM data differ from SMBG data

STEP 1 — Gather Information

Collect device model, wear time, frequency of data review, recent SMBG log, and ask the patient to describe what they see on the CGM screen (numeric value, trend arrows) and what they do with fingerstick results.

STEP 2 — Rule In / Rule Out

Determine if the patient correctly states that CGM measures interstitial glucose with a physiological lag (≈5‑15 min) and displays direction/trend arrows, whereas SMBG provides an instantaneous capillary glucose at a single point in time. If yes, rule in understanding; if not, rule out.

STEP 3 — Classify or Stratify

Classify understanding into: (A) Full – explains lag, trend arrows, and uses trend data for insulin decisions; (B) Partial – knows CGM gives a number but confuses with SMBG or misses lag/trend; (C) None – believes CGM and SMBG are identical or does not know what trend arrows mean. Assign the patient to the appropriate tier.

STEP 4 — Decide

Based on tier: (A) Reinforce and advance to trend‑based dosing strategies; (B) Provide focused teaching on lag, trend interpretation, and calibration requirements; (C) Initiate basic CGM education covering device components, difference from SMBG, and need for confirmatory fingersticks.

Clinical Guardrails / Mimics / Pitfalls

Do not assume that wearing CGM equates to understanding; avoid relying solely on self‑report without probing trend interpretation; do not let patients adjust insulin based solely on CGM without confirmatory SMBG if the device requires calibration; watch for alarm fatigue that may cause patients to ignore trend alerts.

Concrete Clinical Example

A 58‑year‑old with type 1 diabetes wearing a Dexcom G6 reports seeing “120 with an upward arrow.” When asked what the arrow means, they say “My sugar is going up.” They note a fingerstick might differ due to lag and plan to check a fingerstick before dosing if the arrow is steep. This shows partial‑to‑full understanding; the clinician reinforces trend‑based dosing and confirms the calibration schedule.

Source: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2534

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する